Health Canada Asked Pfizer for DNA Fragments Size in COVID Shots, Linked to ‘Probability’ of Genomic ‘Integration’

Canada’s drug regulator asked Pfizer to provide data on the size of DNA fragments in its COVID-19 vaccine, due to genomic integration concerns, shortly after learning the pharma giant withheld information on DNA sequences contained in its product. “Concerning the residual plasmid DNA in the drug substance, provide data/information characterizing […] the size distribution of the residual DNA fragments [and] residual intact circular plasmid,” says a request for clarification Health Canada issued to Pfizer on Aug. 4, 2023. The information was released as part of records obtained through an access-to-information request. It shows, in part, that a Health Canada official was keeping the department’s counterparts in the United States and Europe apprised of the department’s interactions with Pfizer, in a bid to harmonize the regulators’ approaches regarding the recently discovered DNA fragment impurities....